Skip to main content
. 2023 Feb 15;29(3):605–622. doi: 10.3350/cmh.2022.0342

Figure 2.

Figure 2.

Hepatocellular carcinoma risk stratification of untreated HBeAg-negative chronic hepatitis B patients by HBV DNA, HBsAg and HBcrAg. HBcrAg, hepatitis B core-related antigen; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; ALT, alanine aminotransferase; HCC, hepatocellular carcinoma.